July 01, 2015 22:59 (IST)
The re-branding will be executed in two stages. In the first phase, the corporate brand has transitioned to the new identity. The second phase will see the new identity transitioning on to company's product packaging, it said in a statement.
July 01, 2015 18:18 (IST)
Drug firm Aurobindo Pharma on Wednesday said its chief executive officer (formulations) Arvind Vasudeva has resigned from the company.
July 01, 2015 17:35 (IST)
Pharmaceuticals major Zydus Group on Wednesday announced receipt of approval from the US Food and Drug Administration (FDA) to sell chronic pain reliever morphine sulfate tablets.
July 01, 2015 01:32 (IST)
Under the structured deal, Pfizer's wholly-owned subsidiary Perkins would be merged into Hospira. Consequently, Hospira would become a wholly-owned subsidiary of Pfizer.
June 30, 2015 10:41 (IST)
Marksans Pharma shares rose over 9 per cent to touch an intraday high of Rs 64.40 on Tuesday after the company said that it has acquired US-based Time-Cap Laboratories for an undisclosed amount..
June 29, 2015 14:51 (IST)
The firm has started recalling Divalproex Sodium extended-release tablets as it has failed dissolution tests, and Amlodipine Besylate and Atorvastatin Calcium tablets since these are close to expiry time.
June 29, 2015 14:37 (IST)
Two years after its most high-profile regulatory setback to date in the United States - Ranbaxy's $500 million U.S. fine for drug safety violations - India's $15 billion a year generic drug industry is still rebuilding its image in its biggest market.
June 28, 2015 18:51 (IST)
Pharmaceuticals major Lupin is looking at strengthening its branded portfolio by creating alliances and eyeing strategic brand acquisitions in US markets in 2015-16.
June 28, 2015 17:46 (IST)
The government plans to set up a Rs 500-crore venture capital fund to boost the domestic pharmaceutical industry and provide cheaper loans to entities looking to establish or upgrade manufacturing facilities.
June 25, 2015 21:37 (IST)
A Zenotech Laboratories-formed committee of independent directors has termed Sun Pharmaceutical Industries' open offer worth Rs 20.23 crore to acquire a little over 28 per cent stake in the company as "fair and reasonable".
June 25, 2015 20:44 (IST)
The system aims to facilitate online submission of mandatory returns and reports under the Drug Price Control Order (DPCO), 2013 by manufacturers, including companies which make, import, distribute or sell drugs in the country.
June 23, 2015 22:54 (IST)
Innovation and technology will be important differentiators as pharmaceutical companies try to drive growth in emerging markets that face rapid growth of various chronic diseases like diabetes, hypertension, heart disease, and cancer, according to a report.
June 23, 2015 16:06 (IST)
The drug is used to treat adults with infections such as pneumonia, bacterial sinusitis, chronic bronchitis, skin and skin structure infections, chronic bacterial prostatitis, urinary tract infections and inhalational anthrax.
June 23, 2015 10:54 (IST)
Enabling approval of the shareholders to the above will be sought at the Annual General Meeting scheduled for July 23, 2015, it added.
June 22, 2015 13:36 (IST)
Aurobindo Pharma on Monday announced receipt of final approval from the US health regulator to manufacture and market its generic versions of Parkinson's disease treatment drug Entacapone tablets and antibiotics Azithromycin in the American market.
June 21, 2015 19:30 (IST)
According to a filing with Securities and Exchanges Commission, DRL said the company follows a hybrid research and development model, both in-house and virtual (operations are outsourced, subject to supervision of strategic and project management functions).
June 19, 2015 15:47 (IST)
Mylan CEO Heather Bresch, in a separate statement, said: "We have stated all along that the '808 patent on Copaxone is invalid... We continue to remain very confident and look forward to bringing our product to market upon approval from the US Food and Drug Administration."
June 19, 2015 13:55 (IST)
On April 1, the drug firm had said that it would acquire select portfolio of established brands of UCB in India, Nepal, Sri Lanka and Maldives for Rs 800 crore.
June 19, 2015 13:52 (IST)
Copaxone (Glatiramer Acetate) is used in the treatment of relapsing-remitting multiple sclerosis.
June 17, 2015 21:03 (IST)
The approval is with 180 days of generic drug exclusivity, it added.